Planning the Lifecycle of Safety Evaluation

Slides:



Advertisements
Similar presentations
Delete these guides from slide master before printing or giving to the client 1 Bayesian Trial Design – Case studies Panelists Andrew Mugglin, Medtronic.
Advertisements

OPTN Concepts Related to Liver Allocation and Distribution Loews Atlanta Hotel Atlanta, GA April 12, :00am – 5:00pm EDT.
Integrating Cardiovascular Endpoints into toxicology studies: Preliminary Results from An Industry Survey Simon Authier, DVM, MBA, PhD Director - Safety.
January , 2015, Washington D.C. 5 th NACP Principal Investigators Meeting Washington, D.C. January 26 th – 29 th, 2015 Overview of Meeting Agenda.
Industry/FDA/Academia Safety Graphics Working Group Introduction and Overview FDA/QSPI Biostatistics, Statistical Programming, and Data Management Summit.
Welcome to The Accounts Payable Leadership Conference!
1 National Center for Atmospheric Research Boulder, CO October 20-21, 2005 Paul Pisano, Team Leader Road Weather Management Program FHWA Maintenance Decision.
SESSION ONE: PROGRESS Welcome and introduction from conference chair Gill Haynes Vice Chair CHILDREN’S WORKFORCE DEVELOPMENT COUNCIL.
Concurrent Session Facilitator Training Utah Mentor Teacher Academy.
Welcome to ICIUM2011 Anita Wagner Chair, International Scientific Program Committee.
Program Management Introduction / Networking Session 2901.
The Who, What & Where of Warehouse Management at the ASUG Annual Conference.
Interagency Oncology Task Force (IOTF) Research and Regulatory Review Fellowships
Advancing Government through Collaboration, Education and Action Small Business SIG Kimberly Purlia, Chair Purlia Parris, LLC Michael Townsend, Vice Chair.
Welcome to CAMP Leveraging Campus Authentication Across Boundaries Workshop Ann West NMI-EDIT Outreach Michigan Tech/EDUCAUSE/Internet2.
1 Process to Address Specifications for Delivered Dose Uniformity of Inhaled and Nasal Drug Products Presented by Robert O’Neill, Ph.D. Chair ACPS Working.
WNY Institutional Research Leaders Group October 24, 2014.
CPI Conference 2001 Education Tools and How to Access Them Education Committee Chris Hyvonen Kiewit Chris Hyvonen Kiewit.
Class of 2013 Fellows May 20, 2013 Sheraton Boston Hotel Boston, MA USA.
Industry Perspective on Challenges for Product Developers - Drugs Christine Allison, M.S., RAC Associate Regulatory Consultant, Global Regulatory Affairs.
Tadalafil for the Treatment of Pulmonary Arterial Hypertension: A Double-blind 52-week Uncontrolled Extension Study Ronald J. Oudiz, MD, FACC; Bruce H.
SOCIAL DEVELOPMENT DEPARTMENT COMMUNICATION STRATEGY & PLAN.
Respiratory Safety Pharmacology Endpoints in Toxicology Simon Authier, DVM, MBA, PhD Director - Safety Pharmacology and Veterinary Science CIToxLAB North.
Stakeholder Workshop Welcome and Introductions 1 August 25, 2010 Tom Sorel, Minnesota Department of Transportation Vernon Betkey, Maryland Highway Safety.
National Workshop on Universal Health Coverage Overview Health Economics Unit Ministry of Health and Family Welfare.
Complex Aerospace Systems Exchange (CASE) 2012 Conference Planning Committee Meeting 11 Jan 2012.
CNIC 2013: FIRST TIMERS SESSION Sunday, January 13 – 1:00 PM CNIC Program Co-Chairs: Lora Gilbert, Orange County Public Schools, Orlando, FL Kevin Woods,
1 RISK MANAGEMENT PUBLIC WORKSHOPS APRIL 9-11, 2003 NTSB BOARD AND CONFERENCE CENTER WASHINGTON, DC.
Drug Safety and Risk Management Advisory Committee May 18-19, Overview of Drug Safety Challenges Gerald J. Dal Pan, MD, MHS Director Division of.
CSEE Student Research Conference Prof. R. Scott Cost IAB Presentation May 10, 2002.
Highlights Include: Poster Session: over 100 scientific posters displayed throughout the hospital in a variety of areas Mini-Symposia on topics including:
Paws N’ go Dog walking at your services!! Jessica Please contact me at: Address: 508A Scott Road M2m4s1.
HIT Policy Committee Adoption Certification Workgroup Proposed Next Steps Paul Egerman, Chair Marc Probst, Co-Chair July 21, 2010.
Code 800 Diversity Working Group GSFC/Wallops Flight Facility 30 November 2009 FY 09 Diversity Metrics.
1 An introductory workshop for new governors 2005 Becoming a governor.
Registration Management Committee (RMC) Workshop – June 21-22, 2007 “Regulatory Requirements” Americas Aerospace Quality Group Registration Management.
University of Georgia Department of Crop and Soil Sciences 2014 Fall Faculty Meeting August 11, 2014 Athens Campus Athens, GA.
1 RISK MANAGEMENT PUBLIC WORKSHOPS APRIL 9-11, 2003 NTSB BOARD AND CONFERENCE CENTER WASHINGTON, DC.
Local HWTS Monitoring Eva Manzano, CAWST Technical Advisor Laos Vientiane, Lao PDR November 11, 2014.
1 Lotronex ® (alosetron HCl) Tablets Introduction Victor F. C. Raczkowski, M.D. Director, Division of Gastrointestinal and Coagulation Drug Products April.
Medical Writing Special Interest Area Community (SIAC) Medical Communications March Workshop 2012 David Clemow SIAC Chair Melissa Ossanna Communications.
Welcome to our 2011 conference Nigel Magson Chair INSIGHT Special Interest Group Nigel Magson Chair INSIGHT Special Interest Group Tuesday 29 th November,
. Lilly Diabetes Company Confidential Copyright© 2008 Eli Lilly and Company Company Confidential Copyright© 2008 Eli Lilly and Company Career Opportunities.
DIA Annual Meeting 2014 Statistical Science and Quantitative Thinking Track AJ Sankoh, Rima Izem.
FDA’s Role in the Risk Management of Opiate Analgesics Steven Galson, M.D., M.P.H. Deputy Center Director, Center for Drug Evaluation and Research Food.
NAAG Presidential Initiative Challenges in Health Care Cost, Competition and Policy Innovation Attorney General George Jepsen.
Welcome and Presenter:
Microsoft Dynamics CRM User Group (CRMUG®)
WELCOME TO THE 2011 ANNUAL SERC RESEARCH REVIEW
DIA Virtual Journal Club Statistical Considerations on the Evaluation of Imbalances of Adverse Events in Randomized Clinical Trials Discussant Susan.
Name: Barbara Beckerman
Welcome to the 6th Annual
Education Tools and How to Access Them
School-wide Positive Behavioral Interventions & Supports (SWPBIS) Readiness Activity miblsi.org.
Highlights from the DIA Ad-Promo Regulatory Affairs Conference 2017
Presentation title (including which technology you address)
Today’s Agenda Introductions from Student Panel
Self-Publishing Around The World
Opportunity Discussion Methods For More Information
FSMA TRAINING Industry Recall Readiness BEST PRACTICES
Data Monitoring committees and adaptive decision-making
May 18-19, 2010 George Mason University Fairfax, VA
Presenter #1 • Presenter #2 • Presenter #3 Presenter #4 • Presenter #5
Technical Committee Hamid Vakilzadian
Welcome to PLOS 2011! Sixth Workshop on Programming Languages and Operating Systems Cascais, Portugal October 23, 2011.
MedBiquitous Annual Conference 2011
I am a Mighty Wolf! Jaxon.
Presentation title (including which technology you address)
Exchange Session 1: implications of new Directives
Pathways to your future with keynote speaker Lindsay czarniak
Presentation transcript:

Planning the Lifecycle of Safety Evaluation Brenda Crowe, PhD Eli Lilly and Company

Conference Program Committee Brenda Crowe, PhD, Lilly (Co-chair) Wanju Dai, MD, DrPH, sanofi-aventis (Co-chair) Gerald Dal Pan, MD, MHS, FDA Henry “Skip” Francis, MD, FDA Paul Huckle, MD, GlaxoSmithKline Robert O’Neill, PhD, FDA Manfred Oster, MD, sanofi-aventis George Rochester, PhD, RAC, FDA Amy Xia, PhD, Amgen Program Advisors Walt Offen, PhD, Lilly Steve Snapinn, PhD, Lilly

Conference Co-chairpersons In addition to the program committee: Howard Chazin, MD, MBA, FDA Eileen King, PhD, Procter & Gamble Judith Racoosin, MD, MPH, FDA James Hung, PhD, FDA Henry Hsu, PhD, MPH, FDA Jesse Berlin, ScD, Johnson & Johnson Sandra Kweder, MD, FDA

Special Thanks Constance Burnett, DIA Jessica Kusma, DIA Debra Michaels, DIA

Conference Goals Stimulate discussion among FDA and industry participants regarding proactive planning of safety evaluation throughout the lifecycle of drug development. Includes planning for data collection, evaluation (including data monitoring committees), integration, analysis (including meta-analysis) and reporting.

Program Outline—Day 1 9:10 – 10:30: Challenges and Opportunities to Improve Premarketing Safety Planning, Evaluation and Reporting 11:00 – noon, 1:30 – 2:30: Combining Safety Data at a Development Program Level—Data Collection and Study Design: Dirt Road Vs. Super Highway 2:30 – 3:45: How to Improve Safety Data Analysis and Presentation 4:15 – 5:30: Safety Boundaries for Data Monitoring Committees 5:30 - 6:30: Reception

Program Outline—Day 2 8:30 – 8:40: Welcome and Keynote Introduction 8:40 – 9:30: Keynote Presentation (Janet Woodcock) 9:30 – 10:30: Introduction and Overview of Meta-analysis 11:00 – 12:30: Concurrent sessions (Meta-analysis of 1. Rare Events and 2. Observational Data) 1:45 – 3:00: Regulatory Decision Making Based on Meta-analysis Results 3:30 – 4:30: Lessons Learned and Path Forward Panel 4:35: Conference adjourned

Time Session chairs: Please synchronize your watches: It is now: ….9:0X am Very important: We need to stick to allotted time

5 minute

1 minute

minute

Stop Now!! Please -1 minute You’re killing me!